These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6172641)

  • 1. [Effect of angiotensin II on indices of the fibrinolysis system in experiments in vitro].
    Golubenkova NI
    Lab Delo; 1981; (12):720-2. PubMed ID: 6172641
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of the enzyme preparation longolytin on fibrinolysis in animals].
    Serebriakova TN; Andreenko GV; Tsymanovich SG; Maksimova RA; Sharkova TS
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (2):66-71. PubMed ID: 3157406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analytical methods of study of the system of fibrinolysis (plasminogen proactivators-activators, plasminogen-plasmin, antiplasmins, antiactivators) (literature review)].
    Guseĭnov ChS; Golovastova GI; Gorelova AM; Cherenkova GM; Mikhailova ND
    Lab Delo; 1976; (5):276-83. PubMed ID: 62085
    [No Abstract]   [Full Text] [Related]  

  • 4. [Additional potentials of a method of standard fibrin plates].
    Kovalenko AN
    Lab Delo; 1980; (10):615-8. PubMed ID: 6158612
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolysis].
    Levy G; Michault A; Jamet M
    Ann Anesthesiol Fr; 1978; 19(8):703-8. PubMed ID: 31114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the content of finbrinolysis activating and inhibiting factors and of fibrinogen in patients with thrombosis and prethrombotic conditions].
    Andreenko GV
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):195-7. PubMed ID: 50983
    [No Abstract]   [Full Text] [Related]  

  • 7. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinolytic activity of the renal glomerulus. Preliminary results of a histochemical study of plasminogen activity in 44 renal biopsies].
    Arrigo G; Baroni M; Benuzzi S; Bellini A; Chiesa I; Colasanti G; D'Amico G
    Minerva Nefrol; 1979; 26(4):459-62. PubMed ID: 161611
    [No Abstract]   [Full Text] [Related]  

  • 9. [Various fibrinolytic and coagulation characteristics of the blood plasma after contact with N-amyl alcohol].
    Lussa A; Tymińska-Brzósko R
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1979; 24():91-104. PubMed ID: 161647
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of a single administration of plasminogen tissue activator on the state of the fibrinolytic system of rat blood].
    Andreenko GV; Shimonaeva EE; Liutova LV; Serebriakova TN
    Vopr Med Khim; 1981; 27(1):77-80. PubMed ID: 7193381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of the thrombolytic agents.
    Weitz JI
    Baillieres Clin Haematol; 1990 Jul; 3(3):583-99. PubMed ID: 2148696
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis and therapy of consumption coagulopathy].
    Lechner K
    Wien Klin Wochenschr; 1973 Jun; 85(26):467-70. PubMed ID: 4268703
    [No Abstract]   [Full Text] [Related]  

  • 13. Inherited fibrinolytic disorder due to an enhanced plasminogen activator level.
    Aznar J; Estellés A; Vila V; Regañón E; España F; Villa P
    Thromb Haemost; 1984 Oct; 52(2):196-200. PubMed ID: 6543037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplasmins.
    Norman PS
    Fed Proc; 1966; 25(1):63-7. PubMed ID: 4143744
    [No Abstract]   [Full Text] [Related]  

  • 16. [Assay of fibrinolytic factors with plasminogen-free bovine fibrin-agar-plate and its clinical application. I. Some properties of plate and features for estimation of fibrinolytic factors (author's transl)].
    Abe T; Kazama M; Satoh A; Suzuki J; Yamamoto S
    Rinsho Ketsueki; 1975 Oct; 16(10):946-52. PubMed ID: 128644
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibilities of the method of fibrin plates for determination of the activity of the blood fibrinolytic system components].
    Butorov VN; Bokarev IN
    Lab Delo; 1978; (5):271-3. PubMed ID: 79009
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinolytic therapy: biochemical mechanisms.
    Robbins KC
    Semin Thromb Hemost; 1991 Jan; 17(1):1-6. PubMed ID: 1828622
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of some indices of fibrinolysis (fibrinogen, FDP, plasminogen) in mature diabetics].
    Di Cesare E; Quartarone M; Cucinotta D; Coppolino E; Squadrito G
    Minerva Med; 1979 May; 70(22):1597-9. PubMed ID: 450299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.